A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Trial Profile

A Randomized, Double-blind, Multicenter, Phase 3 Study to Evaluate Efficacy and Safety of HCP1401 for Stage 2 Hypertension Patients Not Controlled by HCP0605

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Nov 2017

At a glance

  • Drugs Amlodipine/chlortalidone/losartan (Primary)
  • Indications Hypertension
  • Focus Registrational; Therapeutic Use
  • Sponsors Hanmi Pharmaceutical
  • Most Recent Events

    • 17 Nov 2017 According to a Hanmi Pharmaceutical media release, clinical results from this trial were presented at the 47th Korean Society of Hypertension Fall Conference.
    • 19 Oct 2017 Results published in the Hanmi Pharmaceutical Media Release.
    • 19 Oct 2017 According to a Hanmi Pharmaceutical media release, results were published in SCI-level international scientific journal Clinical Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top